LPCN
Price
$3.32
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
18.41M
TARA
Price
$3.33
Change
-$0.01 (-0.30%)
Updated
Jul 25 closing price
Capitalization
128.48M
16 days until earnings call
Interact to see
Advertisement

LPCN vs TARA

Header iconLPCN vs TARA Comparison
Open Charts LPCN vs TARABanner chart's image
Lipocine
Price$3.32
Change-$0.00 (-0.00%)
Volume$2.63K
Capitalization18.41M
Protara Therapeutics
Price$3.33
Change-$0.01 (-0.30%)
Volume$111.67K
Capitalization128.48M
LPCN vs TARA Comparison Chart in %
Loading...
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPCN vs. TARA commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a Buy and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (LPCN: $3.44 vs. TARA: $3.33)
Brand notoriety: LPCN and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 63% vs. TARA: 33%
Market capitalization -- LPCN: $18.41M vs. TARA: $128.48M
LPCN [@Biotechnology] is valued at $18.41M. TARA’s [@Biotechnology] market capitalization is $128.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, both LPCN and TARA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 5 TA indicator(s) are bullish while TARA’s TA Score has 5 bullish TA indicator(s).

  • LPCN’s TA Score: 5 bullish, 3 bearish.
  • TARA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LPCN is a better buy in the short-term than TARA.

Price Growth

LPCN (@Biotechnology) experienced а +10.42% price change this week, while TARA (@Biotechnology) price change was +6.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

LPCN is expected to report earnings on May 08, 2025.

TARA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($128M) has a higher market cap than LPCN($18.4M). LPCN YTD gains are higher at: -29.508 vs. TARA (-36.932). LPCN has higher annual earnings (EBITDA): -6.42M vs. TARA (-51.1M). TARA has more cash in the bank: 124M vs. LPCN (19.7M). LPCN has less debt than TARA: LPCN (1.48M) vs TARA (4.23M). LPCN has higher revenues than TARA: LPCN (3.68M) vs TARA (0).
LPCNTARALPCN / TARA
Capitalization18.4M128M14%
EBITDA-6.42M-51.1M13%
Gain YTD-29.508-36.93280%
P/E RatioN/AN/A-
Revenue3.68M0-
Total Cash19.7M124M16%
Total Debt1.48M4.23M35%
FUNDAMENTALS RATINGS
LPCN vs TARA: Fundamental Ratings
LPCN
TARA
OUTLOOK RATING
1..100
211
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
6359
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (14) in the null industry is in the same range as LPCN (36) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as LPCN (100) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

LPCN's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as TARA (96) in the null industry. This means that LPCN’s stock grew similarly to TARA’s over the last 12 months.

TARA's Price Growth Rating (59) in the null industry is in the same range as LPCN (63) in the Pharmaceuticals Other industry. This means that TARA’s stock grew similarly to LPCN’s over the last 12 months.

LPCN's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as TARA (100) in the null industry. This means that LPCN’s stock grew similarly to TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPCNTARA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWGAY9.950.08
+0.81%
Swatch Group AG
TSIHF8.23N/A
N/A
TSI Holdings Co., Ltd.
ZHEXF0.98N/A
N/A
Zhejiang Expressway Co. Ltd.
CTGSP3.05N/A
N/A
Connecticut Natural Gas Corp.
NEXNF0.14N/A
-1.87%
Nexe Innovations Inc.

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
+3.61%
SPRY - LPCN
63%
Loosely correlated
-0.28%
IPA - LPCN
43%
Loosely correlated
-6.49%
ZNTL - LPCN
36%
Loosely correlated
N/A
JANX - LPCN
31%
Poorly correlated
-0.04%
TARA - LPCN
30%
Poorly correlated
-0.30%
More